Cite
Anderson E, LeVee A, Kim S, et al. A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer. JAMA Netw Open. 2021;4(12):e2138432doi: 10.1001/jamanetworkopen.2021.38432.
Anderson, E., LeVee, A., Kim, S., Atkins, K., Guan, M., Placencio-Hickok, V., Moshayedi, N., Hendifar, A., Osipov, A., Gangi, A., Burch, M., Waters, K., Cho, M., Klempner, S., Chao, J., Kamrava, M., & Gong, J. (2021). A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer. JAMA network open, 4(12), e2138432. https://doi.org/10.1001/jamanetworkopen.2021.38432
Anderson, Eric, et al. "A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer." JAMA network open vol. 4,12 (2021): e2138432. doi: https://doi.org/10.1001/jamanetworkopen.2021.38432
Anderson E, LeVee A, Kim S, Atkins K, Guan M, Placencio-Hickok V, Moshayedi N, Hendifar A, Osipov A, Gangi A, Burch M, Waters K, Cho M, Klempner S, Chao J, Kamrava M, Gong J. A Comparison of Clinicopathologic Outcomes Across Neoadjuvant and Adjuvant Treatment Modalities in Resectable Gastric Cancer. JAMA Netw Open. 2021 Dec 01;4(12):e2138432. doi: 10.1001/jamanetworkopen.2021.38432. PMID: 34889947.
Copy
Download .nbib